Search
The fight against counterfeit drugs affects every country and that is why it is important that nations work together to stop the deadly scourge. This fact is not lost on Nigeria, which is working with India to ensure that all medicines brought into the African nation are authentic. According to AllAfrica.com, most of the pharmaceutical products in Nigeria come from India…
Read MoreGhanaian religious leaders committed to decreasing child mortality rates decried counterfeit drug purveyors at the 8th Annual National Catholic Health Services Conference (NCHS). The 8th NCHS Annual Conference was held at the Catholic Guest House, Bolgatanga in the Upper East Region of Ghana from October 26 to 29, 2010. The theme was “Monitoring for Continuous Improvement: Using Whole System Measures”.…
Read MoreThe government in Taiwan is currently cracking down on a rapid proliferation in the trade of fake drugs, the China Post reports. Taiwanese Health Minister Yang Chih-liang said during a press conference that counterfeit drugs posed a more serious problem than drug trafficking. The government has been strongly cracking down on counterfeit drugs since March, including pursuing 260 television advertisements…
Read MoreA number of health professionals in Kenya say diseases are becoming more resistant to treatments because of the prevalence of counterfeit drugs in the country. Pharmacists in the African nation said that a campaign should be started to warn consumers that the use of counterfeit drugs can lead to more resilient strands of certain diseases, according to Business Daily Africa. Kenya…
Read MoreHealth Canada is alerting consumers that prescription drugs purchased from www.northdrugmart.com, www.northdrugstore.com, and www.pharmacyrxworld.com are suspected of being counterfeit. Health Canada has identified prescription drugs for sale on these websites have not been authorized for sale in Canada, and yet they reference brand names and resemble drugs that have been authorized for sale in Canada. Consumers who have…
Read MoreThe beginning of a criminal investigation by Russian authorities in Moscow of a prominent spammer has resulted in a significant reduction in the amount of spam advertising from illegal online pharmacies, reports the New York Times. The center of the investigation, Igor A. Gusev, has been linked to the website “SpamIt”, an organization that provides financial incentives for spammers to…
Read MoreA new study from Cambridge Consultants details some of the challenges facing developers of anti-counterfeiting technology, according to a new white paper written in coordination with the BIO 2010 conference in Chicago. Summarizing a panel discussion between Lew Kontnik, Director of Brand Protection for Amgen, David Kent, Vice President of Global Risk at Genzyme, Andrew Emmett, director for Science and Regulatory Affairs at…
Read MoreA Grand Forks, North Dakota doctor has pled guilty on federal charges of conspiracy to distribute a controlled substance. His counsel says that he client didn’t know he was breaking the law and even paid taxes on his earnings. Authorities say Enrique Rivera Mass, 56, illegally signed off on prescriptions for nearly 1.8 million pills that were sold online. While…
Read MoreAn FDA chemist uses a high performance liquid chromatograph (HPLC) to test drug samples.Photo courtesy of the U.S. Government, via Flickr.
Read More
The Food and Drug Administration Office of Regulatory Affairs has increased regulation of imported goods by 35% over the past five years, employing more than 2,000 analysts and conducting more than 100,000 analyses annually, says David Elder of the FDA Office of Regulatory Affairs.
Working cooperatively with the U.S. Customs and Border Protection and other agencies, the FDA uses a targeted, risk-based approach to electronically examine 100% of imported drug products followed by additional reviews by FDA imports personnel to ensure key compliance, says David Elder, regional operations director in the Food and Drug Administration (FDA) Office of Regulatory Affairs.
Read the full interview with David Elder, as reprinted from FDA Consumer Updates under Read More below.